(1R,2R,3R,6R,7S,8S,9R,10R,13Z,16R,18R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2,7-dihydroxy-2,6,8,10,16,18-hexamethyl-13-(quinolin-3-ylmethylidene)-4,11,15-trioxabicyclo[8.5.4]nonadecane-5,17-dione

C42H62N2O10 — CID 10485241

IUPAC(1R,2R,3R,6R,7S,8S,9R,10R,13Z,16R,18R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2,7-dihydroxy-2,6,8,10,16,18-hexamethyl-13-(quinolin-3-ylmethylidene)-4,11,15-trioxabicyclo[8.5.4]nonadecane-5,17-dione
SMILESCC[C@H]1OC(=O)[C@H](C)[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@]2(C)C[C@@H](C)C(=O)[C@H](C)[C@@H](OC/C(=C/c3cnc4ccccc4c3)CO2)[C@]1(C)O
InChIInChI=1S/C42H62N2O10/c1-11-33-42(8,49)38-25(4)34(45)23(2)19-41(7,51-22-29(21-50-38)17-28-18-30-14-12-13-15-31(30)43-20-28)37(26(5)35(46)27(6)39(48)53-33)54-40-36(47)32(44(9)10)16-24(3)52-40/h12-15,17-18,20,23-27,32-33,35-38,40,46-47,49H,11,16,19,21-22H2,1-10H3/b29-17-/t23-,24-,25+,26+,27-,32+,33-,35+,36-,37-,38-,40+,41-,42-/m1/s1
InChIKeyMZTAZZVFEWBXLC-QHZKDAPQSA-N
MW754.96 g/mol
LogP4.55
Rot. Bonds5

About (1R,2R,3R,6R,7S,8S,9R,10R,13Z,16R,18R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2,7-dihydroxy-2,6,8,10,16,18-hexamethyl-13-(quinolin-3-ylmethylidene)-4,11,15-trioxabicyclo[8.5.4]nonadecane-5,17-dione

(1R,2R,3R,6R,7S,8S,9R,10R,13Z,16R,18R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2,7-dihydroxy-2,6,8,10,16,18-hexamethyl-13-(quinolin-3-ylmethylidene)-4,11,15-trioxabicyclo[8.5.4]nonadecane-5,17-dione (PubChem CID 10485241) has the molecular formula C42H62N2O10 and a molecular weight of 754.96 g/mol. Its IUPAC name is (1R,2R,3R,6R,7S,8S,9R,10R,13Z,16R,18R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2,7-dihydroxy-2,6,8,10,16,18-hexamethyl-13-(quinolin-3-ylmethylidene)-4,11,15-trioxabicyclo[8.5.4]nonadecane-5,17-dione.

Molecular Properties

Compound Name(1R,2R,3R,6R,7S,8S,9R,10R,13Z,16R,18R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2,7-dihydroxy-2,6,8,10,16,18-hexamethyl-13-(quinolin-3-ylmethylidene)-4,11,15-trioxabicyclo[8.5.4]nonadecane-5,17-dione
PubChem CID10485241
Molecular FormulaC42H62N2O10
Molecular Weight754.96 g/mol
Exact Mass754.44
IUPAC Name(1R,2R,3R,6R,7S,8S,9R,10R,13Z,16R,18R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2,7-dihydroxy-2,6,8,10,16,18-hexamethyl-13-(quinolin-3-ylmethylidene)-4,11,15-trioxabicyclo[8.5.4]nonadecane-5,17-dione
SMILESCC[C@H]1OC(=O)[C@H](C)[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@]2(C)C[C@@H](C)C(=O)[C@H](C)[C@@H](OC/C(=C/c3cnc4ccccc4c3)CO2)[C@]1(C)O
InChIInChI=1S/C42H62N2O10/c1-11-33-42(8,49)38-25(4)34(45)23(2)19-41(7,51-22-29(21-50-38)17-28-18-30-14-12-13-15-31(30)43-20-28)37(26(5)35(46)27(6)39(48)53-33)54-40-36(47)32(44(9)10)16-24(3)52-40/h12-15,17-18,20,23-27,32-33,35-38,40,46-47,49H,11,16,19,21-22H2,1-10H3/b29-17-/t23-,24-,25+,26+,27-,32+,33-,35+,36-,37-,38-,40+,41-,42-/m1/s1
InChIKeyMZTAZZVFEWBXLC-QHZKDAPQSA-N
XLogP4.55
TPSA157.11 Ų
H-Bond Donors3
H-Bond Acceptors12
Rotatable Bonds5
Heavy Atoms54
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500754.96
LogP ≤ 54.55
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1012

Analyze (1R,2R,3R,6R,7S,8S,9R,10R,13Z,16R,18R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2,7-dihydroxy-2,6,8,10,16,18-hexamethyl-13-(quinolin-3-ylmethylidene)-4,11,15-trioxabicyclo[8.5.4]nonadecane-5,17-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1R,2R,3R,6R,7S,8S,9R,10R,13Z,16R,18R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2,7-dihydroxy-2,6,8,10,16,18-hexamethyl-13-(quinolin-3-ylmethylidene)-4,11,15-trioxabicyclo[8.5.4]nonadecane-5,17-dione?
The IUPAC name of (1R,2R,3R,6R,7S,8S,9R,10R,13Z,16R,18R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2,7-dihydroxy-2,6,8,10,16,18-hexamethyl-13-(quinolin-3-ylmethylidene)-4,11,15-trioxabicyclo[8.5.4]nonadecane-5,17-dione (CID 10485241) is (1R,2R,3R,6R,7S,8S,9R,10R,13Z,16R,18R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2,7-dihydroxy-2,6,8,10,16,18-hexamethyl-13-(quinolin-3-ylmethylidene)-4,11,15-trioxabicyclo[8.5.4]nonadecane-5,17-dione.
What is the SMILES notation for (1R,2R,3R,6R,7S,8S,9R,10R,13Z,16R,18R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2,7-dihydroxy-2,6,8,10,16,18-hexamethyl-13-(quinolin-3-ylmethylidene)-4,11,15-trioxabicyclo[8.5.4]nonadecane-5,17-dione?
The canonical SMILES for (1R,2R,3R,6R,7S,8S,9R,10R,13Z,16R,18R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2,7-dihydroxy-2,6,8,10,16,18-hexamethyl-13-(quinolin-3-ylmethylidene)-4,11,15-trioxabicyclo[8.5.4]nonadecane-5,17-dione is CC[C@H]1OC(=O)[C@H](C)[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@@]2(C)C[C@@H](C)C(=O)[C@H](C)[C@@H](OC/C(=C/c3cnc4ccccc4c3)CO2)[C@]1(C)O.
What is the InChIKey of (1R,2R,3R,6R,7S,8S,9R,10R,13Z,16R,18R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2,7-dihydroxy-2,6,8,10,16,18-hexamethyl-13-(quinolin-3-ylmethylidene)-4,11,15-trioxabicyclo[8.5.4]nonadecane-5,17-dione?
The InChIKey is MZTAZZVFEWBXLC-QHZKDAPQSA-N. The full InChI is InChI=1S/C42H62N2O10/c1-11-33-42(8,49)38-25(4)34(45)23(2)19-41(7,51-22-29(21-50-38)17-28-18-30-14-12-13-15-31(30)43-20-28)37(26(5)35(46)27(6)39(48)53-33)54-40-36(47)32(44(9)10)16-24(3)52-40/h12-15,17-18,20,23-27,32-33,35-38,40,46-47,49H,11,16,19,21-22H2,1-10H3/b29-17-/t23-,24-,25+,26+,27-,32+,33-,35+,36-,37-,38-,40+,41-,42-/m1/s1.
What are the key properties of (1R,2R,3R,6R,7S,8S,9R,10R,13Z,16R,18R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2,7-dihydroxy-2,6,8,10,16,18-hexamethyl-13-(quinolin-3-ylmethylidene)-4,11,15-trioxabicyclo[8.5.4]nonadecane-5,17-dione?
(1R,2R,3R,6R,7S,8S,9R,10R,13Z,16R,18R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2,7-dihydroxy-2,6,8,10,16,18-hexamethyl-13-(quinolin-3-ylmethylidene)-4,11,15-trioxabicyclo[8.5.4]nonadecane-5,17-dione has a molecular weight of 754.96 g/mol, XLogP of 4.55, 5 rotatable bonds, 3 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,2R,3R,6R,7S,8S,9R,10R,13Z,16R,18R)-9-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-3-ethyl-2,7-dihydroxy-2,6,8,10,16,18-hexamethyl-13-(quinolin-3-ylmethylidene)-4,11,15-trioxabicyclo[8.5.4]nonadecane-5,17-dione is sourced from PubChem (CID 10485241), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).